§ Mr. BurstowTo ask the Secretary of State for Health what information his Department collects from the
A B C E F Deaths1 in England and Wales where the
underlying cause of
death2 was hepatitis C3
Deaths in UK of HIV- infected individuals with
Deaths in HIV-infected individuals who have
given blood
Deaths in UK from vCJD
Blood donors traced by UKBS who died from
vCJD
1998 92 507 5 18 2 1999 92 467 5 15 1 2000 125 475 5 28 3 2001 123 381 2 20 1 2002 4— 310 2 17 2 1 These figures are likely to underestimate the true mortality related to hepatitis C for several reasons: the certifying doctor may not always know about the existence of a hepatitis C infection, contracted many years earlier, that had given rise to another fatal liver disease.
318WSchool of Health and Related Research at the University of Sheffield regarding the risk sharing agreement for beta interferon and glatiramer. [107569]
§ Mr. LammyThe Sheffield University School for Health and Related Research (ScHARR) is responsible for collecting and analysing information on health outcomes for patients who receive disease-modifying therapies for multiple sclerosis (MS) under the United Kingdom risk sharing scheme. Information relating to progress in setting up the network of centres who will be providing data to ScHARR is routinely provided to members of the project monitoring group representing the parties to the scheme, including professional bodies, the MS Society and MS Trust, the companies marketing the four products, and UK health departments. ScHARR is not responsible for wider aspects of implementation of the scheme.